The (near) equivalence of cost-effectiveness and cost-benefit analyses. Fact or fallacy?

C Donaldson
Author Information
  1. C Donaldson: Health Economics Research Unit, University of Aberdeen, Scotland. c.donaldson@abdn.ac.uk

Abstract

There has been much recent debate in the health economics literature as to the (near) equivalence of cost-benefit analysis (CBA) and cost-effectiveness analysis (CEA). The aim of this paper is to demonstrate that whether such a (near) equivalence exists depends on whether one defines economic evaluations as 'CBA' or 'CEA' on the basis of either what is measured or what question the analyst is seeking to answer. The former basis of definition is popular within the 'decision science' approach to economic evaluation, but does not seem to have any theoretical support. If the latter, more theoretically correct, basis is accepted, there is no longer a case for the (near) equivalence of CBA and CEA.

References

  1. J Health Econ. 1997 Feb;16(1):33-64 [PMID: 10167344]
  2. BMJ. 1991 May 11;302(6785):1119-22 [PMID: 1904286]
  3. N Engl J Med. 1995 May 25;332(21):1418-24 [PMID: 7723799]
  4. Health Policy. 1994 May;28(2):133-41 [PMID: 10136058]
  5. Health Care Anal. 1997 Mar;5(1):7-29 [PMID: 10166053]
  6. Health Policy. 1995 Sep;33(3):219-31 [PMID: 10145123]
  7. J Health Econ. 1992 Oct;11(3):279-96 [PMID: 10122540]
  8. J Clin Oncol. 1997 Feb;15(2):640-5 [PMID: 9053488]
  9. J Health Econ. 1987 Sep;6(3):211-25 [PMID: 10312255]
  10. J Clin Oncol. 1997 Feb;15(2):632-9 [PMID: 9053487]
  11. Soc Sci Med. 1995 Aug;41(4):483-9 [PMID: 7481942]
  12. Pharmacoeconomics. 1997 Feb;11(2):115-8 [PMID: 10172934]
  13. Pharmacoeconomics. 1992 Jan;1(1):54-67 [PMID: 10147039]
  14. Clin Ther. 1995 Jan-Feb;17(1):109-25 [PMID: 7758053]
  15. Pharmacoeconomics. 1992 Jan;1(1):20-31 [PMID: 10147037]
  16. J Health Econ. 1997 Feb;16(1):1-31 [PMID: 10167341]
  17. Int J Technol Assess Health Care. 1991;7(1):12-21 [PMID: 1903360]
  18. Lancet. 1977 Apr 16;1(8016):844-7 [PMID: 67348]
  19. Gynecol Oncol. 1997 Sep;66(3):454-63 [PMID: 9299261]
  20. N Engl J Med. 1997 Jan 30;336(5):332-6 [PMID: 9011785]
  21. CMAJ. 1993 Mar 15;148(6):913-7 [PMID: 8448705]

MeSH Term

Cost-Benefit Analysis
Economics, Pharmaceutical

Word Cloud

Created with Highcharts 10.0.0nearequivalencebasiscost-benefitanalysisCBAcost-effectivenessCEAwhethereconomicmuchrecentdebatehealtheconomicsliteratureaimpaperdemonstrateexistsdependsonedefinesevaluations'CBA''CEA'eithermeasuredquestionanalystseekinganswerformerdefinitionpopularwithin'decisionscience'approachevaluationseemtheoreticalsupportlattertheoreticallycorrectacceptedlongercaseanalysesFactfallacy?

Similar Articles

Cited By